乌斯特基努马
医学
溃疡性结肠炎
回顾性队列研究
中心(范畴论)
维多利祖马布
儿科
内科学
疾病
阿达木单抗
化学
结晶学
作者
Shlomi Cohen,Helena Rolandsdotter,Kaija-Leena Kolho,Dan Turner,Christos Tzivinikos,Matteo Bramuzzo,Gemma Pujol‐Muncunill,Luca Scarallo,Darja Urlep,Firas Rinawi,Maya Granot,Ben Kang,Ylva Longueville,Marta Velasco Rodríguez‐Belvís,Yael Weintraub,Víctor Manuel Navas‐López,Anat Yerushalmy‐Feler
出处
期刊:Pediatric Drugs
[Adis, Springer Healthcare]
日期:2024-05-23
卷期号:26 (5): 609-617
被引量:14
标识
DOI:10.1007/s40272-024-00631-z
摘要
Based on these findings, ustekinumab appears as an effective therapy for pediatric refractory UC and IBDU. The potential efficacy should be weighed against the risks of serious adverse events.
科研通智能强力驱动
Strongly Powered by AbleSci AI